Article (Scientific journals)
Pembrolizumab‐induced migrating cortico‐subcortical brain lesions
Lambert, Nicolas; Steinmetz, Maximilien; SIBILLE, Anne et al.
2021In Annals of Neurology
Peer Reviewed verified by ORBi
 

Files


Full Text
Article version finale AON.pdf
Publisher postprint (1.66 MB)
Request a copy

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
pembrolizumab; immune checkpoint inhibitor; programmed cell death protein 1; immune-related adverse events; encephalitis
Disciplines :
Immunology & infectious disease
Neurology
Author, co-author :
Lambert, Nicolas  ;  Centre Hospitalier Universitaire de Liège - CHU > Département de médecine interne > Service de neurologie
Steinmetz, Maximilien ;  Centre Hospitalier Universitaire de Liège - CHU > Département de médecine interne > Service de neurologie
SIBILLE, Anne ;  Centre Hospitalier Universitaire de Liège - CHU > Département de médecine interne > Service de pneumologie - allergologie
SADZOT, Bernard ;  Centre Hospitalier Universitaire de Liège - CHU > Département de médecine interne > Service de neurologie
Language :
English
Title :
Pembrolizumab‐induced migrating cortico‐subcortical brain lesions
Publication date :
27 February 2021
Journal title :
Annals of Neurology
ISSN :
0364-5134
eISSN :
1531-8249
Publisher :
John Wiley & Sons, Hoboken, United States - New York
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 16 March 2021

Statistics


Number of views
112 (17 by ULiège)
Number of downloads
5 (4 by ULiège)

Scopus citations®
 
0
Scopus citations®
without self-citations
0
OpenCitations
 
1

Bibliography


Similar publications



Contact ORBi